Safety and Efficacy of Dorzagliatin in Patients with Type 2 Diabetes under Real-World Clinical Practice: Preliminary Results from a Large-Scale Post-marketing Study
Read More
2026 ADA Poster
Dorzagliatin improves glycemic control in type 2 diabetes patients with different time in range (TIR): A subgroup analysis of 6-month interim results from a prospective real-world study
Read More
2026 ADA Oral Presentation
Synergistic Effects of Dorzagliatin and Orforglipron on Glycemic Control and Adiposity in DIO Mice
Copyright ? 2026 Hua Medicine (Shanghai) Ltd. 沪网药械信备字【2026】000123号 沪ICP备14036654号-1沪公网安备 31011502013809号Privacy StatementTerms of Use
Search
How we use cookies
Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.